🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honored to receive this award from American Heart Association #ReSS21!! Please look forward to presentation #8875, a collaboration between Sun Yat-sen University, Rush University System for Health, and @UTSWNews. RUSH Internal Medicine Jochen Reiser MD PhD AnnabelleVolgman MD Kim Williams

Our study led by Zhi Yu found that genetic deficiency of IL6 signaling significantly attenuates CKD-associated CAD risk. This implies that IL6 signaling inhibition may be an efficient strategy to reduce CAD risk among patients with CKD. sciencedirect.com/science/articl… JACC Journals

Nature medicine review: A guide to immunotherapy for COVID-19 The review aims to support clinical decision-making by providing an overview of the evidence generated by major clinical trials of host-directed therapy. Read the full review: go.nature.com/3oes3h3 #suPAR

My great #HeForShe  colleagues Rush University System for Health sent me pics of them wearing red! Thanks Kim Williams Rami Doukky David Luo et al. Mamas A. Mamas John P Erwin III MD MBA MACC (#BigPoppy ) Robert Harrington Don Lloyd-Jones Eugene Yang mike valentine MD MACC,FSCAI,FAHA Parikshit S Sharma, MD, MPH, FACC, FHRS Jeremy Wasserlauf Henry D. Huang clifford jay kavinsky Hussam Suradi Fareed Moses Collado, MD FACC FSCAI

Paper with incredible effort that concludes on an increased and persistent cardiovascular risk from #Covid19. 👇

#NephMadness 2022: The Year That Cardiology and Nephrology Are Friends Erin D. Michos, M.D. #Cardiorenal ajkdblog.org/2022/03/24/nep…

Lower AKI risk found in dabigatran users - Results from our systematic review and network meta-analysis on oral anticoagulants in AF now online! AnnabelleVolgman MD Kim Williams Henry D. Huang Jeremy Wasserlauf Melissa Tracy Yumeng Wen Laith A. Derbas Jochen Reiser MD PhD. doi.org/10.1016/j.ahjo…

Finally out ! Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for PWAS | ⁦Nature Genetics⁩ ⁦Morgan Grams⁩ ⁦@JoeCoresh⁩ ⁦Nilanjan Chatterjee⁩ ⁦Jingning Zhang⁩ nature.com/articles/s4158…

1/17 🤔Why do we use epinephrine to treat cardiac arrest? Epinephrine can CAUSE cardiac arrest. And yet we give it as part of ACLS to treat the condition it caused. This paradox requires explanation.

1/10 Does epinephrine improve outcomes in patients with cardiac arrest? This is a question with a complex answer. This thread is only meant to scratch the surface and is a follow-up to a recent tweetorial on the use of epinephrine for cardiac arrest.

Excited to share new data from #ISIC Study linking high #suPAR level to risk for venous thromboembolism in patients hospitalized for #COVID19: ahajrnls.org/3bSux1O. Thanks to all my coauthors Salim S. Hayek, MD Jochen Reiser MD PhD AnnabelleVolgman MD Kim Williams Alexi Vasbinder, PhD, RN Cardiac Biomarkers Lab Jesper Eugen-Olsen

>3000 patients were analyzed to learn that suPAR levels are higher in HF compared to non-HF, are strongly and independently predictive of outcomes, and combined with BNP, significantly improved risk prediction. ⁦Salim S. Hayek, MD⁩ ⁦AnnabelleVolgman MD⁩ 👇👇 sciencedirect.com/science/articl…

So great to be with our future cardiologists! ⁦Rush University System for Health⁩ ⁦RUSH Internal Medicine⁩ residents presented their abstracts ⁦AHAMeetings⁩ #AHA22! ⁦Jochen Reiser MD PhD⁩ ⁦Kim Williams⁩ ⁦Parikshit S Sharma, MD, MPH, FACC, FHRS⁩ ⁦clifford jay kavinsky⁩ ⁦Karolina Marinescu MD⁩ ⁦Lynne Braun, PhD⁩

Thrilled to be joining this class and start cardiology fellowship Johns Hopkins Cardiology !! Really grateful to mentors Jochen Reiser MD PhD AnnabelleVolgman MD Kim Williams Jeffrey Soble Scott Hasler and so many more RUSH Cardiology Rush University System for Health who have helped make this possible.

LDL-Cholesterol Is Predominantly Associated With Atherosclerotic CVD Events in Patients With Evidence of Coronary Atherosclerosis: Western Denmark Heart Registry Johns Hopkins Ciccarone Center @HopkinsHeart #🥍🎾⛳️ahajournals.org/doi/10.1161/CI…

Excited to share our new publication in Circulation: Genomic and Precision Medicine!! Lower CV and all-cause mortality seen with higher circulating #BCAAs in advanced, non-diabetic CKD. Thanks to coauthors Morgan Grams @JoeCoresh Drs. Appel, Rebholz, &Surapaneni #AASK #CardioTwitter ahajournals.org/doi/abs/10.116…

Huge news about REPRIEVE Trial- the 1st statin vs placebo primary prevention CV outcomes trial in HIV prematurely stopped by DSMB for overwhelming efficacy. 35% reduction in MACE! (given other pitavastatin studies, likely ~30 mg/dl LDL-C-lowering) nih.gov/news-events/ne… [1/3]

EMPA-KIDNEY results are broadly generalizable and could benefit ~3 million adults in the US with CKD Totality of SGLT2i data in CKD, ~5 million eligible Individuals With Chronic Kidney Disease Qualifying for SGLT-2 Inhibito... sciencedirect.com/science/articl… Muthu Vaduganathan Dr. Deepak L. Bhatt

Is it 7/1 yet? We're so excited to welcome our incoming class for the start of their Cardiology Fellowship journey😊 Johns Hopkins Medicine

#EuroPCR #JACC LBCT SimPub: Insights from #REVIVED-BCIS2 trial - Completeness of #revascularization, whether anatomical or viability-guided, does not influence outcomes in patients with ischemic #cardiomyopathy. bit.ly/44JRcV0 Saad Ezad Margaret McEntegart Cardiac Research